Sunil Healthcare Ltd. has announced a board meeting outcome approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025. The auditors issued an unmodified opinion, confirming the accuracy of the financial statements. The company has decided not to declare any dividend for the financial year 2024-25. The Board approved appointing M/s. ATCS & Associates as Secretarial Auditor for five years starting FY 2025-26, subject to member approval, and appointed M/s. Agrawal S. Lal & Co. as Internal Auditors for FY 2025-26. The Board also approved the Directors’ Report for 2024-25.